Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro

Dovitinib (TKI-258) is under development for the treatment of diverse cancer entities. No published information on its pharmacokinetic drug interaction potential is available. Thus, we assessed its interaction with important drug metabolising enzymes and drug transporters and its efficacy in multidr...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiß, Johanna (Author) , Theile, Dirk (Author) , Dvorak, Zdenek (Author) , Haefeli, Walter E. (Author)
Format: Article (Journal)
Language:English
Published: 16 December 2014
In: Pharmaceutics
Year: 2014, Volume: 6, Issue: 4, Pages: 632-650
ISSN:1999-4923
DOI:10.3390/pharmaceutics6040632
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3390/pharmaceutics6040632
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1999-4923/6/4/632
Get full text
Author Notes:Johanna Weiss, Dirk Theile, Zdenek Dvorak and Walter Emil Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1735744107
003 DE-627
005 20220818230941.0
007 cr uuu---uuuuu
008 201016s2014 xx |||||o 00| ||eng c
024 7 |a 10.3390/pharmaceutics6040632  |2 doi 
035 |a (DE-627)1735744107 
035 |a (DE-599)KXP1735744107 
035 |a (OCoLC)1341371241 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
245 1 0 |a Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro  |c Johanna Weiss, Dirk Theile, Zdenek Dvorak and Walter Emil Haefeli 
264 1 |c 16 December 2014 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.10.2020 
520 |a Dovitinib (TKI-258) is under development for the treatment of diverse cancer entities. No published information on its pharmacokinetic drug interaction potential is available. Thus, we assessed its interaction with important drug metabolising enzymes and drug transporters and its efficacy in multidrug resistant cells in vitro. 
650 4 |a CYPs 
650 4 |a dovitinib 
650 4 |a drug transporters 
650 4 |a drug-drug interaction 
650 4 |a tyrosine kinase inhibitor 
700 1 |a Theile, Dirk  |e VerfasserIn  |0 (DE-588)1019114428  |0 (DE-627)684195658  |0 (DE-576)356996360  |4 aut 
700 1 |a Dvorak, Zdenek  |e VerfasserIn  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t Pharmaceutics  |d Basel : MDPI, 2009  |g 6(2014), 4, Seite 632-650  |h Online-Ressource  |w (DE-627)614096529  |w (DE-600)2527217-2  |w (DE-576)313958653  |x 1999-4923  |7 nnas  |a Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro 
773 1 8 |g volume:6  |g year:2014  |g number:4  |g pages:632-650  |g extent:19  |a Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro 
856 4 0 |u https://doi.org/10.3390/pharmaceutics6040632  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1999-4923/6/4/632  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201016 
993 |a Article 
994 |a 2014 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
998 |g 1019114428  |a Theile, Dirk  |m 1019114428:Theile, Dirk  |d 910000  |d 910100  |e 910000PT1019114428  |e 910100PT1019114428  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1735744107  |e 3780577518 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"name":{"displayForm":["Johanna Weiss, Dirk Theile, Zdenek Dvorak and Walter Emil Haefeli"]},"note":["Gesehen am 16.10.2020"],"person":[{"given":"Johanna","display":"Weiß, Johanna","family":"Weiß","role":"aut"},{"family":"Theile","role":"aut","given":"Dirk","display":"Theile, Dirk"},{"display":"Dvorak, Zdenek","given":"Zdenek","role":"aut","family":"Dvorak"},{"given":"Walter E.","display":"Haefeli, Walter E.","family":"Haefeli","role":"aut"}],"recId":"1735744107","physDesc":[{"extent":"19 S."}],"id":{"eki":["1735744107"],"doi":["10.3390/pharmaceutics6040632"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro","title":"Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro"}],"origin":[{"dateIssuedDisp":"16 December 2014","dateIssuedKey":"2014"}],"relHost":[{"pubHistory":["1.2009 -"],"note":["Gesehen am 28.05.14"],"language":["eng"],"part":{"volume":"6","year":"2014","issue":"4","extent":"19","pages":"632-650","text":"6(2014), 4, Seite 632-650"},"disp":"Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitroPharmaceutics","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"614096529","name":{"displayForm":["Molecular Diversity Preservation International"]},"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisher":"MDPI"}],"title":[{"title":"Pharmaceutics","title_sort":"Pharmaceutics"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["614096529"],"issn":["1999-4923"],"zdb":["2527217-2"]}}]} 
SRT |a WEISSJOHANINTERACTIO1620